Eli Lilly is planning to launch its blockbuster type 2 diabetes drug Mounjaro (tirzepatide) in India as early as next year, according to e Reuters. Mounjaro is currently under review by Indian health authorities, with Lilly having submitted data from its global clinical trials that included Indian patients. Tirzepatide, the...